Stanford researchers develop treatment that restores cartilage and reverses arthritis in mice and human tissue
Stanford Medicine researchers have restored lost knee cartilage in aging mice and prevented post-injury arthritis by blocking a protein called 15-PGDH, with human tissue samples from knee replacement patients also showing cartilage regrowth after one week of treatment. The study, published in the journal Science, identifies 15-PGDH as a "gerozyme" — a protein that increases with age and suppresses tissue regeneration — and found that inhibiting it shifts cartilage cells toward a younger, healthier state without requiring stem cells. The findings raise the possibility of injectable or oral treatments that could slow or reverse osteoarthritis, a condition affecting roughly one in five U.S. adults with no currently approved disease-modifying therapies.
A Stanford Medicine-led study published in Science reports that blocking the protein 15-PGDH dramatically restored knee cartilage in older mice and prevented osteoarthritis from developing after ACL-type injuries. The treatment works by inhibiting a class of age-associated proteins called gerozymes, which suppress prostaglandin E2, a molecule critical for tissue regeneration. Rather than activating stem cells, the treatment appeared to reprogram existing cartilage-producing cells called chondrocytes, shifting their gene expression toward healthier, more youthful patterns — a mechanism the researchers describe as a novel form of adult tissue regeneration. In mice, both systemic and locally injected forms of the drug produced significant cartilage thickening, and treated animals walked more normally after injury. Crucially, cartilage samples taken from human patients undergoing knee replacement surgery also responded to the treatment in lab conditions, showing reduced cartilage-degrading activity and new articular cartilage formation after one week. A 15-PGDH inhibitor is already in Phase 1 clinical trials for age-related muscle weakness and has shown a safety profile in healthy volunteers, which the researchers say could accelerate a similar trial for cartilage regeneration. Several of the study's senior authors hold equity in Epirium Bio, a company that has licensed Stanford's related patents, representing a financial conflict of interest that warrants consideration.
What's missing
The study's key limitations include that mouse cartilage biology does not always translate to humans, and the human tissue results were conducted ex vivo (in lab dishes) rather than in living patients — no human clinical trial for cartilage regeneration has yet been conducted. The optimal dosing, delivery method, and long-term safety of 15-PGDH inhibition in humans remain unknown. It is also unclear whether the cartilage regrowth observed is durable over time or whether it would be sufficient to produce meaningful clinical improvement in patients with advanced osteoarthritis.
What different sources said
- Science DailyCenter
Stanford scientists regrow lost cartilage and reverse arthritis in major breakthrough
Related
Tick Populations Surge in Urban Areas Across Northeast
Tick populations are expanding into urban green spaces and reaching record early-season activity levels across the northeastern United States and Canada, alarming public health officials. Submissions to Pennsylvania's tick research lab rose 50 percent in March and April, Washington D.C. saw bites a month earlier than usual, and a Canadian researcher collected 13 ticks in a single hour. The spread raises concerns not only about Lyme disease but also about alpha-gal syndrome, an emerging red-meat allergy triggered by lone star tick bites that is reshaping daily life and local economies in heavily affected areas.
Study suggests eating 5 fruits and vegetables daily may not provide enough heart-protective compounds
A new study published in the journal Food & Function found that fewer than 25% of people who met standard fruit and vegetable dietary guidelines consumed enough flavanols — plant compounds linked to cardiovascular benefits — to reach the 500mg daily threshold associated with a 27% reduction in cardiovascular disease mortality. Researchers from the University of Reading, Harvard Medical School, UC Davis, and Mars, Inc. analyzed dietary and biomarker data from more than 30,000 adults in the US and UK. The findings suggest that the specific types of fruits and vegetables consumed matter as much as the total quantity, pointing to a potential gap in current dietary guidance.
New blood test can detect thousands of genetic conditions in pregnancy without invasive procedures
Scientists have developed a maternal blood test called non-invasive fetal sequencing (NIFS) that can detect thousands of serious genetic conditions in a developing fetus with 95–99% accuracy compared to invasive methods. The test analyzes fragments of fetal DNA circulating in the mother's bloodstream and was validated on 565 pregnancies, identifying variants across nearly 23,000 genes. It could reduce reliance on procedures like amniocentesis, which carry a small but real risk of miscarriage.